Related Experiment Video
Updated: Jul 12, 2026
12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
Aaron T Gerds1, Jason Gotlib2, Peter Abdelmessieh3
11Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Summary
NCCN Guidelines offer updated recommendations for Philadelphia chromosome-negative myeloproliferative neoplasms (MPN), focusing on myelofibrosis care. These insights reflect expert consensus on managing these heterogeneous hematologic malignancies.
Area of Science:
- Hematology
- Oncology
- Clinical Guidelines
Background:
- Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) encompass myelofibrosis, polycythemia vera, and essential thrombocythemia.
- These are heterogeneous hematologic malignancies characterized by abnormal blood cell proliferation.
Purpose of the Study:
- To provide updated, comprehensive care recommendations for adult patients with MPNs.
- To focus on recent advancements and guideline changes specifically for myelofibrosis.
Main Methods:
- Development of NCCN Guidelines by a multidisciplinary panel of MPN experts.
- Annual meetings to review requested changes and evaluate emerging scientific data.
Main Results:
- Recent updates to the NCCN Guidelines for MPN, with a specific focus on myelofibrosis management.
- Incorporation of new data and expert consensus into clinical recommendations.
Conclusions:
- The updated guidelines aim to enhance the comprehensive care of adults with myelofibrosis and other Philadelphia chromosome-negative MPNs.
- Regular evaluation of emerging data ensures guidelines remain current for these complex hematologic malignancies.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...